Bliss GVS Pharma Ltd. (BLISSGVS-BE): Bliss GVS Pharma Share Price hits fresh 52-week high on NSE

Bliss GVS Pharma Share Price is trading at Rs 691.4, up 3.39%, after touching a fresh 52-week high of Rs 702.1. The company’s market capitalisation stands at Rs 7,110.32 crore, and the latest move keeps Bliss GVS Pharma Stock News in focus.

Bliss GVS Pharma Share Price is trading at Rs 691.4, up Rs 22.7 or 3.39%, after touching a fresh 52-week high of Rs 702.1. The stock opened at Rs 680, moved between Rs 673.05 and Rs 702.1, and is valued at a market capitalisation of Rs 7,110.32 crore. For investors tracking Bliss GVS Pharma Share Price Today, the event matters because it confirms a new yearly high in market trading, while the latest Univest data also places the move in the context of valuation and sector comparison. The price event is verified; the latest Univest data does not establish a company-specific catalyst. That makes Bliss GVS Pharma Stock News a data-led story rather than a reason-led one.

Bliss GVS Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 691.4
Previous Close	Rs 668.7
Today's Move	+Rs 22.7 (+3.39%)
Open	Rs 680
High	Rs 702.1
Low	Rs 673.05
Turnover	Rs 0.1 crore
Market Capitalisation	Rs 7,110.32 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 691.4 versus the previous close of Rs 668.7, a rise of 3.39%. The stock opened at Rs 680, reached a high of Rs 702.1 and touched a low of Rs 673.05.

Bliss GVS Pharma Share Price Today shows a clear intraday rise from the previous close of Rs 668.7 to Rs 691.4. The stock added Rs 22.7 and touched Rs 702.1, which is also the fresh 52-week high. It opened at Rs 680 and saw a low of Rs 673.05, so the day’s range was Rs 29.05. The move above the previous 52-week high of Rs 702.1 was not applicable because the same level stands as the current yearly high, which means the stock is trading at the top of its one-year range. Turnover stood at Rs 0.1 crore. In Bliss GVS Pharma Share Price terms, the latest session data confirms a firm price update and keeps Bliss GVS Pharma Share Price Live on the radar for market updates.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7,110.32 crore
P/E Ratio	52.21x
P/B Ratio	5.77x
ROE	12.11%
ROCE	17.4%
EPS	Rs 12.81
Book Value Per Share	Rs 115.94
Dividend Yield	0.22%

Bliss GVS Pharma Ltd. (BLISSGVS-BE) fundamental metrics show P/E 52.21x, P/B 5.77x, ROE 12.11%, ROCE 17.4%. These figures provide context only and are not a buy or sell signal.

Bliss GVS Pharma Ltd. has a market capitalisation of Rs 7110.32 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 52.21x, P/B at 5.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 12.81, book value per share of Rs 115.94, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.47x, median ROE of 11.78%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	52.21x
Benchmark Median P/E	32.47x
Benchmark Average P/E	48.77x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	5.77x
Benchmark Median P/B	2.89x
Company ROE	12.11%
Benchmark Median ROE	11.78%
Company ROCE	17.4%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 7,110.32 crore
Benchmark Median Market Cap	Rs 673.68 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 52.21x, which is above the benchmark median of 32.47x, a difference of +60.79%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of 12.11%, which is above the benchmark median of 11.78%, a difference of +2.8%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 17.4%, which is above the benchmark median of 13.63%, a difference of +27.66%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sanofi India Ltd.	SANOFI	7,254.65	22.4	8.78	44.5	55.46
SYMBIOTEC PHARMALAB LTD	SYMBIOTEC	6,932.91	63.08	4.67	11.22	12.41
Supriya Lifescience Ltd.	SUPRIYA	6,882.89	34.7	5.63	19.06	25.3
Innova Captab Ltd.	INNOVACAP	6,720.78	43	5.92	13.75	15.04
SENORES PHARMACEUTICALS L	SENORES	6,572.31	52.01	6.82	14.14	15.66

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 52.21x compared with the displayed peer median of 43x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.11% compares with a peer median of 14.14% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 15.66%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 7,110.32 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Bliss GVS Pharma

• Bliss GVS Pharma Share Price touched a fresh 52-week high of Rs 702.1.
• Bliss GVS Pharma Share Price Today is Rs 691.4, up 3.39% from the previous close.
• The market capitalisation is Rs 7,110.32 crore.
• P/E is 52.21 and P/B is 5.77, both above the same-industry median.
• ROE is 12.11% and ROCE is 17.4%, both above the same-industry medians.

About Bliss GVS Pharma

Bliss GVS Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked on NSE under the symbol BLISSGVS-BE. In the latest Univest data, the business is represented through market capitalisation, valuation ratios, profitability measures and recent quarterly financial figures. For readers following Bliss GVS Pharma Company News, the stock’s current event-led profile is shaped by a fresh yearly high, a market cap above Rs 7,000 crore and a valuation that sits above the industry median.

Frequently Asked Questions

Why is Bliss GVS Pharma Share Price in the news today?

Ans. Bliss GVS Pharma Share Price is in focus because it touched a fresh 52-week high of Rs 702.1 and is trading at Rs 691.4, up 3.39% from the previous close.

What is the current Bliss GVS Pharma Share Price Today?

Ans. Bliss GVS Pharma Share Price Today is Rs 691.4. It is higher than the previous close of Rs 668.7 and has moved within an intraday range of Rs 673.05 to Rs 702.1.

What is the 52-week high for Bliss GVS Pharma Share Price?

Ans. The fresh 52-week high for Bliss GVS Pharma Share Price is Rs 702.1. The stock touched that level during the current market move and is trading near that yearly peak.

How much did Bliss GVS Pharma Share Price rise today?

Ans. Bliss GVS Pharma Share Price rose by Rs 22.7, or 3.39%, versus the previous close. That move lifted the stock into a fresh yearly high zone during the trading session.

What is the market capitalisation of Bliss GVS Pharma?

Ans. Bliss GVS Pharma has a market capitalisation of Rs 7,110.32 crore. That places it close to the market-cap range of several listed pharmaceutical peers in the latest comparison set.

How does Bliss GVS Pharma look on valuation?

Ans. Bliss GVS Pharma trades at a P/E of 52.21 and a P/B of 5.77. Both are above the same-industry median, which gives the share price a higher valuation backdrop.

What do ROE and ROCE show for Bliss GVS Pharma Share Price?

Ans. ROE is 12.11% and ROCE is 17.4%. Both are above the sector medians, which helps frame Bliss GVS Pharma Share Price alongside profitability and capital-use measures. The stock moved 3.39% so far today.

What should investors monitor next for Bliss GVS Pharma?

Ans. Investors can monitor how Bliss GVS Pharma Share Price trades relative to Rs 702.1, along with updates in valuation ratios, quarterly revenue, net profit and sector comparisons on Univest.

Track Bliss GVS Pharma Share Price on Univest

Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Bliss GVS Pharma Share Price on Univest for live share price updates, market capitalisation, P/E ratio, P/B ratio, EPS, book value, dividend yield, sector context, peer comparison and 52-week levels. Univest brings the latest Bliss GVS Pharma Stock News and Bliss GVS Pharma Share Price Update in one place for quick review.